137 participants
A Post-Marketing Surveillance Study to Assess the Safety of Fedratinib in Korean Patients With Myelofibrosis
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2024-11-06
- Start Date:
- 2023-06-13
- Completion:
- 2027-12-20
Conditions
- Primary Myelofibrosis
- Post-polycythemia Vera Myelofibrosis
- Post-essential Thrombocythemia Myelofibrosis
Interventions
- DRUG
No Results Yet